Abstract
In the hematopoietic cell system, the oncoprotein Ski dramatically affects growth and differentiation programs, in some cases leading to malignant leukemia. However, little is known about the interaction partners or signaling pathways involved in the Ski-mediated block of differentiation in hematopoietic cells. Here we show that Ski interacts with PU.1, a lineage-specific transcription factor essential for terminal myeloid differentiation, and thereby represses PU.1-dependent transcriptional activation. Consistent with this, Ski inhibits the biological function of PU.1 to promote myeloid cells to differentiate into macrophage colony-stimulating factor receptor (M-CSFR)-positive macrophages. Using a Ski mutant deficient in PU.1 binding, we demonstrate that Ski–PU.1 interaction is critical for Ski's ability to repress PU.1-dependent transcription and block macrophage differentiation. Furthermore, we provide evidence that Ski-mediated repression of PU.1 is due to Ski's ability to recruit histone deacetylase 3 to PU.1 bound to DNA. Since inactivation of PU.1 is closely related to the development of myeloid leukemia and Ski strongly inhibits PU.1 function, we propose that aberrant Ski expression in certain types of myeloid cell lineages might contribute to leukemogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
21 February 2008
An Erratum to this paper has been published: https://doi.org/10.1038/sj.onc.1211002
Abbreviations
- ChIP:
-
chromatin immunoprecipitation
- EMSA:
-
electrophoretic mobility shift assay
- HDAC:
-
histone deacetylase
- M-CSFR:
-
macrophage colony-stimulating factor receptor
- TGF-β:
-
transforming growth factor-β
- TPA:
-
12-O-tetradecanoylphorbol-13-acetate
- TSA:
-
trichostatin A
References
Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K et al. (1999). c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with Smads. J Biol Chem 274: 35269–35277.
Ano S, Pereira R, Pironin M, Lesault I, Milley C, Lebigot I et al. (2004). Erythroblast transformation by FLI-1 depends upon its specific DNA binding and transcriptional activation properties. J Biol Chem 279: 2993–3002.
Behre G, Whitmarsh AJ, Coghlan MP, Hoang T, Carpenter CL, Zhang DE et al. (1999). c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem 274: 4939–4946.
Beug H, Dahl R, Steinlein P, Meyer S, Deiner EM, Hayman MJ . (1995). In vitro growth of factor-dependent multipotential hematopoietic cells is induced by the nuclear oncoprotein v-Ski. Oncogene 11: 59–72.
Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC . (2007). The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein–protein interaction. J Biol Chem 282: 6473–6483.
Dahl R, Kieslinger M, Beug H, Hayman MJ . (1998). Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. Proc Natl Acad Sci USA 95: 11187–11192.
Dahl R, Simon MC . (2003). The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Blood Cells Mol Dis 31: 229–233.
Fukuchi M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Sohda M et al. (2004). Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer 108: 818–824.
Jepsen K, Rosenfeld MG . (2002). Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci 115: 689–698.
Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Shinagawa T et al. (2001). Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Mol Cell 7: 1233–1243.
Kronenwett R, Butterweck U, Steidl U, Kliszewski S, Neumann F, Bork S et al. (2005). Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia. Oncogene 24: 5313–5324.
Larsen J, Beug H, Hayman MJ . (1992). The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation. Oncogene 7: 1903–1911.
Larsen J, Meyer S, Steinlein P, Beug H, Hayman MJ . (1993). Transformation of chicken bone marrow cells by the v-ski oncogene. Oncogene 8: 3221–3228.
Liu X, Sun Y, Weinberg RA, Lodish HF . (2001). Ski/Sno and TGF-beta signaling. Cytokine Growth Factor Rev 12: 1–8.
Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S et al. (1999). The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev 13: 2196–2206.
McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H et al. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15: 5647–5658.
Metcalf D, Dakic A, Mifsud S, Di Rago L, Wu L, Nutt S . (2006). Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci USA 103: 1486–1491.
Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, Grimber G et al. (1996). Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol 16: 2453–2463.
Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, Colmenares C et al. (1999). Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev 13: 412–423.
Ohneda K, Yamamoto M . (2002). Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Haematol 108: 237–245.
Reddy VA, Iwama A, Iotzova G, Schulz M, Elsasser A, Vangala RK et al. (2002). Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 100: 483–490.
Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D, Medrano EE . (2001). Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res 61: 8074–8078.
Rekhtman N, Radparvar F, Evans T, Skoultchi AI . (1999). Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 13: 1398–1411.
Ritter M, Kattmann D, Teichler S, Hartmann O, Samuelsson MK, Burchert A et al. (2006). Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 20: 437–443.
Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y et al. (2004). Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36: 624–630.
Scott EW, Simon MC, Anastasi J, Singh H . (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573–1577.
Simon MC, Olson M, Scott E, Hack A, Su G, Singh H . (1996). Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. Curr Top Microbiol Immunol 211: 113–119.
Stavnezer E, Gerhard DS, Binari RC, Balazs I . (1981). Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus. J Virol 39: 920–934.
Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA . (1999). Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell 4: 499–509.
Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Oikawa T . (2003). Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene 22: 8688–8698.
Tokitou F, Nomura T, Khan MM, Kaul SC, Wadhwa R, Yasukawa T et al. (1999). Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion. J Biol Chem 274: 4485–4488.
Ueki N, Hayman MJ . (2003a). Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling. J Biol Chem 278: 32489–32492.
Ueki N, Hayman MJ . (2003b). Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J Biol Chem 278: 24858–24864.
Ueki N, Zhang L, Hayman MJ . (2004). Ski negatively regulates erythroid differentiation through its interaction with GATA1. Mol Cell Biol 24: 10118–10125.
Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG et al. (2003). The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood 101: 270–277.
Xu W, Angelis K, Danielpour D, Haddad MM, Bischof O, Campisi J et al. (2000). Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci USA 97: 5924–5929.
Zhang DE, Hetherington CJ, Chen HM, Tenen DG . (1994). The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 14: 373–381.
Zhang P, Behre G, Pan J, Iwama A, Wara-Aswapati N, Radomska HS et al. (1999). Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA 96: 8705–8710.
Zhang P, Zhang X, Iwama A, Yu C, Smith KA, Mueller BU et al. (2000). PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96: 2641–2648.
Acknowledgements
We thank J Ghysdael and R Dahl for valuable reagents; K Donnelly for supporting our research project and the members of the Hayman laboratory for helpful discussions and criticisms on the manuscript. This work was supported by grant CA42573 from the National Institutes of Health (to MJH).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ueki, N., Zhang, L. & Haymann, M. Ski can negatively regulates macrophage differentiation through its interaction with PU.1. Oncogene 27, 300–307 (2008). https://doi.org/10.1038/sj.onc.1210654
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210654
Keywords
This article is cited by
-
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
Communications Biology (2022)
-
Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease
Signal Transduction and Targeted Therapy (2018)
-
SIAH proteins: critical roles in leukemogenesis
Leukemia (2013)
-
Ski Overexpression in Skeletal Muscle Modulates Genetic Programs That Control Susceptibility to Diet‐Induced Obesity and Insulin Signaling
Obesity (2012)
-
c-Ski in health and disease
Cell and Tissue Research (2012)